Silence Therapeutics Plc Adr (SLN)

Oct 16, 2024

80+ Pharma Companies Unite to Shape the Future of RNA-Based Therapeutics | DelveInsight - 新浪香港

Oct 16, 2024

Sep 30, 2024

Silence Therapeutics's SWOT analysis: stock poised for growth in genetic medicine By Investing.com - Investing.com South Africa

Sep 30, 2024

Sep 30, 2024

Silence Therapeutics's SWOT analysis: stock poised for growth in genetic medicine - Investing.com

Sep 30, 2024

Sep 02, 2024

It makes sense and dollars to buy Silence Therapeutics Plc ADR (SLN) stock - SETE News

Sep 02, 2024

Sep 02, 2024

Silence Therapeutics Plc ADR (SLN) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News

Sep 02, 2024

Sep 02, 2024

What Did We Find About Insider Trading At Silence Therapeutics Plc ADR (NASDAQ: SLN)? - Stocks Register

Sep 02, 2024

Sep 02, 2024

Silence Therapeutics shares start at Buy from Jefferies, reflecting strong clinical data - Investing.com UK

Sep 02, 2024

Aug 30, 2024

H.C. Wainwright reiterates Buy on Silence Therapeutics stock amid strong trial results By Investing.com - Investing.com South Africa

Aug 30, 2024

Aug 15, 2024

How did Silence Therapeutics Plc ADR (SLN) fare last session? - US Post News

Aug 15, 2024

Aug 15, 2024

Ratio Revelations: Silence Therapeutics Plc ADR (SLN)’s Financial Metrics in the Spotlight - The Dwinnex

Aug 15, 2024

Aug 09, 2024

Silence Therapeutics Plc ADR (SLN) deserves closer scrutiny - US Post News

Aug 09, 2024

Aug 09, 2024

Market Insight: Silence Therapeutics Plc ADR (SLN)’s Notable Drop, Closing at 16.70 - The Dwinnex

Aug 09, 2024

Jul 25, 2024

It would be worthwhile to take a closer look at Silence Therapeutics Plc ADR (SLN) - US Post News

Jul 25, 2024

Jul 12, 2024

Silence Therapeutics (SLN) Moves 5.8% Higher: Will This Strength Last? - Yahoo Finance

Jul 12, 2024

Jul 04, 2024

Silence Therapeutics Plc ADR (SLN) deserves closer scrutiny – US Post News - US Post News

Jul 04, 2024

Jun 28, 2024

Silence Therapeutics stock holds Buy rating on positive trial results By Investing.com - Investing.com India

Jun 28, 2024

Jun 26, 2024

Zacks Industry Outlook Highlights Dyne Therapeutics, Silence Therapeutics, Alaunos Therapeutics, Assertio Holdings and Acer Therapeutics - Yahoo Lifestyle UK

Jun 26, 2024

Jun 25, 2024

Hardman & Co Insight: Survival of the UK life sciences sector - Research Tree

Jun 25, 2024

Jun 24, 2024

Cathie Wood's ARK ETF focuses on PagerDuty, 10X Genomics stock By Investing.com - Investing.com

Jun 24, 2024

Jun 21, 2024

Altria maintains stock target, Buy rating on FDA move By Investing.com - Investing.com UK

Jun 21, 2024

Jun 20, 2024

Zerlasiran shows promise in phase 2 study for cardiovascular risk By Investing.com - Investing.com

Jun 20, 2024

Jun 19, 2024

Is Silence Therapeutics Plc ADR (SLN) a good investment opportunity? – US Post News - US Post News

Jun 19, 2024

May 30, 2024

Trading Day Triumph: Silence Therapeutics Plc ADR (SLN) Ends at 21.54, a -2.49 Surge/Plunge – DWinneX - The Dwinnex

May 30, 2024

May 17, 2024

European Equities Traded in the US as American Depositary Receipts Start Week Off Lower Monday - MSN

May 17, 2024

Apr 29, 2024

Kirby Corp CEO sells shares worth over $360k By Investing.com - Investing.com

Apr 29, 2024

Apr 12, 2024

Silence Therapeutics (SLN) Surges 5.7%: Is This an Indication of Further Gains? - Yahoo Finance

Apr 12, 2024

Mar 13, 2024

BMO maintains $67 stock target on Silence Therapeutics stock By Investing.com - Investing.com UK

Mar 13, 2024

Feb 28, 2024

Silence Therapeutics PLC Sponsored ADR (SLN) Soars 6.4%: Is Further Upside Left in the Stock? - Yahoo Finance

Feb 28, 2024

Feb 24, 2024

Silence Therapeutics: Multiple 2024 Catalysts Make This mRNA Biotech Worth A Look - Seeking Alpha

Feb 24, 2024

Feb 16, 2024

Recursion Pharmaceuticals (RXRX) Surges 13.8%: Is This an Indication of Further Gains? - Yahoo Finance

Feb 16, 2024

Jan 11, 2024

All You Need to Know About Silence Therapeutics PLC Sponsored ADR (SLN) Rating Upgrade to Strong Buy - Yahoo Finance UK

Jan 11, 2024

Dec 06, 2023

Does Silence Therapeutics PLC Sponsored ADR (SLN) Have the Potential to Rally 187.05% as Wall Street Analysts Expect? - Yahoo Finance

Dec 06, 2023

Nov 20, 2023

Wall Street Analysts Predict a 361.54% Upside in Silence Therapeutics PLC Sponsored ADR (SLN): Here's What You ... - Yahoo Finance UK

Nov 20, 2023

Nov 01, 2023

symbol__ Stock Quote Price and Forecast - CNN

Nov 01, 2023

Sep 19, 2023

BioCryst (BCRX) Surges 9.9%: Is This an Indication of Further Gains? - Yahoo Canada Finance

Sep 19, 2023

Feb 09, 2021

The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues - Benzinga

Feb 09, 2021

Jan 28, 2021

The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO - Benzinga

Jan 28, 2021

Jan 06, 2021

The Daily Biotech Pulse: Aerpio Reviews Strategic Options, Hologic Goes Shopping - Yahoo Finance

Jan 06, 2021

Oct 06, 2020

The Daily Biotech Pulse: Pfizer, BioNTech Begin European Filing For Coronavirus Vaccine, Y-mAbs BLA Rejected, GlycoMimetics Granted Rare Pediatric Disease Designation - Yahoo Finance

Oct 06, 2020

Oct 02, 2020

The Daily Biotech Pulse: Mesoblast Slumps On FDA Rejection, AstraZeneca's Breakthrough Therapy Designation, 3 IPOs - Yahoo Finance

Oct 02, 2020

Feb 26, 2014

Silence Therapeutics A Quieter Name In RNAi (NASDAQ:SLN) - Seeking Alpha

Feb 26, 2014